Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

Terminated

• Conditions: Cancer; Venous Thromboembolism

• Registration Number: NCT00303407
• Lead Sponsor: University Hospital, Geneva

Brief Summary

To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Detailed Description

Not available

Study Timeline

• Study Start: 2001-01
• Study Completion: 2002-07
• Status Verified: 2005-12
• Study First Submitted: 2006-03-15
• Study First Submitted QC: 2006-03-15
• Last Update Submitted: 2006-03-15
• Study First Posted: 2006-03-16
• Last Update Posted: 2006-03-16

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Cancer patients in palliative care
• Patients fully informed about their condition
• Signed informed consent
• No exclusion criteria

Exclusion Criteria

• Absence of advanced cancer
• Cancer previously cured
• Venous thromboembolism diagnosed within 6 months prior to inclusion
• Absence of discerning capacity
• Active anti-thrombotic treatment with heparins or coumarines
• Thrombocytopenia <50G/l
• PTT >45sec
• TP<35%
• Active bleeding
• Renal failure <20ml/min
• Past history of heparin-induced thrombocytopenia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Center of Continuous Care, chemin de la Savonnière; 🇨🇭 Collonge-Bellerive (Geneva), Geneva, Switzerland